|
Re: Dr. Mark Day interview with Proactive Investors at BIO CEO
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 12, 2019 11:25AM
|
|
Re: New Share Price Contest
|
1
|
Resverlogix Corp.
|
Oct 11, 2019 03:01PM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
1
|
Zenith Epigenetics
|
Jan 27, 2023 09:55AM
|
|
Re: Halted
|
1
|
Zenith Epigenetics
|
Mar 09, 2023 01:47PM
|
|
Re: Any day now......
|
1
|
Resverlogix Corp.
|
May 28, 2021 01:34PM
|
|
Re: It finally happened this morning!
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 16, 2022 01:43PM
|
|
Re: Just got word....
|
1
|
Resverlogix Corp.
|
May 30, 2019 04:23PM
|
|
Re: I'll believe
|
1
|
Zenith Epigenetics
|
Oct 30, 2022 05:08PM
|
|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
1
|
Resverlogix Corp.
|
Oct 07, 2019 10:21AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
1
|
Resverlogix Corp.
|
Jun 14, 2020 12:54PM
|
|
Re: Can Hepalink afford US rights?
|
1
|
Resverlogix Corp.
|
Feb 04, 2019 03:51PM
|
|
Re: Exercise of options Norma Biln
|
1
|
Resverlogix Corp.
|
Jul 29, 2020 02:42PM
|
|
Re: CNBC at the JPM Bio Tech Conference
|
1
|
Resverlogix Corp.
|
Jan 07, 2019 10:10AM
|
|
Another Promissory Note -Exempt Distribution
|
1
|
Zenith Epigenetics
|
Jul 17, 2024 07:21AM
|
|
BNN Bloomberg
|
1
|
Resverlogix Corp.
|
Apr 23, 2019 01:00PM
|
|
Re: COLCORONA trial: Colchicine reduces the risk of COVID-19-related complications
|
1
|
Resverlogix Corp.
|
Jan 24, 2021 08:04AM
|
|
Re: Combined effects of BTI & RVX
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 06, 2021 11:42AM
|
|
Re: What's the deal with Zenith?
|
1
|
Zenith Epigenetics
|
Jun 22, 2023 05:00PM
|
|
Re: EDITRe: i would love to hear,..
|
1
|
Resverlogix Corp.
|
Dec 06, 2019 08:59AM
|
|
Re: IR response
|
1
|
Resverlogix Corp.
|
May 06, 2022 10:35AM
|
